Vaxcyte has advanced to the Phase II trial’s second and final stage (Stage 2) assessing its 31-valent pneumococcal conjugate ...

Growth of Prevnar has been driven lately by use in adults, however, and it is here that Pfizer is facing a challenge from Merck and its V114 pneumococcal conjugate vaccine candidate. The Prevnar ...

For now, however, the Prevnar brand remains largely unscathed ... "Despite the availability of current pneumococcal conjugate vaccines, many adults remain vulnerable to pneumococcal disease ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma.

Pneumococcal conjugate vaccines (PCVs) are known to provide protection against vaccine serotype pneumococcal pneumonia; uncertainty exists regarding the optimum PCV dosing schedule. Methods ...

Antimicrobial resistance and serotypes in Streptococcus pneumoniae have been evolving with the widespread use of antibiotics and the introduction of pneumococcal conjugate vaccines (PCV).

He said there are four registered influenza vaccine brands, but only two are currently actively available in the market. They are Vaxigrip Tetra (Sanofi) and Influvac Tetra (Abbott), both of which ...

The company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.